Immunohistochemical findings of nitric oxide synthase expression in urothelial transitional cell carcinoma including dysplasia

Citation
H. Hayashi et al., Immunohistochemical findings of nitric oxide synthase expression in urothelial transitional cell carcinoma including dysplasia, ONCOL REP, 8(6), 2001, pp. 1275-1279
Citations number
28
Categorie Soggetti
Oncology
Journal title
ONCOLOGY REPORTS
ISSN journal
1021335X → ACNP
Volume
8
Issue
6
Year of publication
2001
Pages
1275 - 1279
Database
ISI
SICI code
1021-335X(200111/12)8:6<1275:IFONOS>2.0.ZU;2-R
Abstract
Several in vitro studies have shown that nitric oxide (NO) produced by NO s ynthase (NOS), such as inducible NOS (iNOS) play an important role in tumor biology. We immunohistochemically examined the expression of iNOS and p53 proteins in patients with transitional cell carcinoma (TCC) of the urinary tract, including adjacent dysplastic lesions to determine the significance of the tumor behavior. Of total 94 tumors, in the present study, 41 (43.6%) tumors exhibited homogeneous immunostaining (diffuse strong positivity in tumor cells, > 60%) and 53 (56.4%) tumors heterogeneous staining (variable positivity in tumor cells, 20-60%). No TCCs exhibited negative iNOS immunos taining, was found. Thirty (31.9%) of 94 TCCs were positive with anti-p53 a ntibody, including 23 of homogeneous and 7 of heterogeneous staining. Of 23 TCCs with homogeneous p53 immunostaining, 11 tumors exhibited homogeneous iNOS immunoreaction. In the present study, dysplastic lesions adjacent to c arcinomas were detected in 64 cases including 36 TCCs with homogeneous iNOS expression. All dysplastic lesions adjacent to the 36 TCCs with homogeneou s iNOS immunostaining exhibited homogeneous iNOS immunostaining. No signifi cant association between iNOS immunoreactivity and any clinicopathological factors as well as p53 immuno-reactivity were found. These in vivo findings provide evidence for frequent iNOS protein expression in TCC. In addition, our observations indicate that overexpression of iNOS expression may be on e of the early events in the carcinogenesis of TCC.